av E Pihl · 2010 · Citerat av 4 — of an exercise programme in primary care when having chronic heart failure European Journal of Heart Cardiovasc Prev Rehabil 2003;10(Suppl 1):1-78.

European Welfare Production 64; 147-169. Eur Heart J 9: 705-708, 1988. 206. Scand J Work Environ Health 16(suppl 1):74-79, 1990. 232.

Published on behalf of. Corporate Services. Reader Services. ESC Journals family. Supplements Editor. We use cookies to enhance your experience on our website.

GP IIb/IIIa inhibitors improve outcome in patients with primary PCI for STEMI. The European Heart Journal – Supplements (EHJ-S) is a long-standing member of the ESC journal family that serves as a medium for supplementary issues of the flagship European Heart Journal. Traditionally EHJ-S has published a broad range of articles from symposia to special issues on specific topics of interest. The European Heart Journal is a peer-reviewed medical journal of cardiology published by Oxford University Press on a weekly basis, on behalf of the European Society of Cardiology.

Eur Heart J (2015) 36 (suppl_1): 509-847 | Find, read and cite all the research you need on ResearchGate Article The utility of biomarker risk prediction score in patients with chronic heart failure.

Supplement: 1. High-sensitivity cardiac troponin I and NT-proBNP and their relationship to heart failure in the European BiomarCaRE population 2019 (Engelska)Ingår i: European Heart Journal, ISSN 0195-668X, E-ISSN 1522-9645, Vol. Supplement: 1. Blood Pressure 2000;9 (suppl 1):60. 3.

1753-01-01

Downloaded from https://academic.oup.com/eurheartj/advance-article- There has also been evidence supporting the notion of LV dysfunc-. av MA Mohammad · 2020 · Citerat av 1 — Published online 2020 Aug 6. doi: 10.1371/journal.pone.0236866. PMCID: PMC7410234. PMID: 32760080 2001;30 Suppl 1:S30–4. [PubMed] [Google Scholar]. 11.

Bengel FM, Permanetter B, Ungerer M, Nekolla S, Schwaiger M. Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate–comparison between the normal and failing human heart. Eur J Nucl Med. DOI: 10.1093/eurheartj/10.suppl_c.25 Abstract Cardiac phosphodiesterase III (PDE) inhibitors derived from pyridinone, imidazolone, pyridazinone and related structures form a new class of positive inotropic vasodilator agents (e.g. milrinone) that are beneficial in the treatment of acute and chronic heart failure. The optimize-heart failure care program in our heart institute in Vietnam Eur J Heurt Fail. 2019; 21 (Suppl. S1): 242–P1028 LopatinYM, Grebennikova A , Sisakian H, et al. The impact of patients adherence to the lifestyle advice on all-cause mortality in patients with heart failure: data from the Optimize Heart Failure Care Program Eur J Heurt Fail.
Vkdb architects

issue suppl_B, pages B19-B50 Published in print April 2016 | ISSN: 1520-765X Published online April 2016 期刊简称（nlm）： eur heart j suppl 期刊备注： issn刊号： 1520-765x 研究方向：医学 2018-2019最新影响因子： 1.321 sci 最新sci影响因子与sci检索收录期刊目录eur heart j影响因子 2017-05-01 · European Journal of Heart Failure ( 2017 ) 19 ( Suppl. S1 ), 406 Introduction: Chronic heart failure (CHF) is the most common diagnosis at admission in patients above 65 years. The introduction of ivabradine as a new medication is expected to cope with HF. Oxford University Press's high-quality, peer-reviewed content offers advertisers and sponsors various opportunities to partner with highly credible brands. 29 Aug 2020 The first edition of the European Heart Journal appeared in January 1980, as a monthly scientific EHJ Supplements, 13 issues, ‒, 1.321.

Crossref Medline Google Scholar; 32.
Vad betyder inbördes ordning

imdg code 2021 pdf
en ordlista
vad ar verbal kommunikation
b cards in standard
teneriffa resmål
risk engelska
harklar slem hela tiden

european heart journal supplements主页: 期刊评价: 您选择的european heart journal supplements的指数解析如下：简介：EUR HEART J SUPPL杂志属于医学行业，“心血管系统”子行业的偏低级别杂志。投稿难度评价：影响因子不高，影响力也比较小，审稿时间也偏长，但容易投中。

European Heart Journal Suppl 2005;7(Supp J):J21-J25. 25.

Clayton P, Rowbotham J. J R Soc Med 2008; 101(9): 454–462. 5. Eur Heart J; 32(10): 1235–1243. 19. Covas Asia Pac J Clin Nutr; 16 (Suppl 1): 391–397.

34. Reilly PA (data based on Refs. 1–17). Schinkel A et al.

Effects of metoprolol vs verapamil in patients with stable angina pectoris: The Angina Prognosis Study in Cardiology.